Insider Ownership
CEOPatel Sushil
Chief Executive Officer
OtherXynos Konstantinos
Chief Medical Officer
CFOHill Emily Luisa
Chief Financial Officer
OtherSarchi Christopher
Chief Commercial Officer
OtherSchwendenman Andrew
Chief Accounting Officer
Transactions
50 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|
| 2025-12-09 | Dhingra Kapil | - | Sale+OE | 3,169 | $10.40 | $32,957.60 | -100% | → |
| 2025-12-02 | Patel Sushil | Chief Executive Officer | Sell | 10,000 | $11.13 | $111,300.00 | -2.9% | → |
| 2025-11-17 | Xynos Konstantinos | Chief Medical Officer | Sell | 7,248 | $9.10 | $65,956.80 | -4.9% | → |
| 2025-11-17 | Sarchi Christopher | Chief Commercial Officer | Sell | 5,208 | $9.10 | $47,392.80 | -4.1% | → |
| 2025-08-15 | Hill Emily Luisa | Chief Financial Officer | Sell | 9,154 | $5.37 | $49,156.98 | -6.4% | → |
| 2025-05-20 | Xynos Konstantinos | Chief Medical Officer | Sell | 7,952 | $8.06 | $64,093.12 | -5.1% | → |
| 2025-05-20 | Astley-Sparke Philip | - | Sell | 32,279 | $8.06 | $260,168.74 | -2.2% | → |
| 2025-05-20 | Hill Emily Luisa | Chief Financial Officer | Sell | 2,535 | $8.05 | $20,406.75 | -1.7% | → |
| 2025-05-20 | Schwendenman Andrew | Chief Accounting Officer | Sell | 3,287 | $8.05 | $26,460.35 | -4.6% | → |
| 2025-05-20 | Patel Sushil | Chief Executive Officer | Sell | 25,105 | $8.06 | $202,346.30 | -6.8% | → |
| 2025-05-20 | Sarchi Christopher | Chief Commercial Officer | Sell | 3,749 | $8.05 | $30,179.45 | -2.8% | → |
| 2024-12-16 | Patel Sushil | Chief Executive Officer | Sell | 10,000 | $12.42 | $124,200.00 | -4.7% | → |
| 2024-11-18 | Sarchi Christopher | Chief Commercial Officer | Sell | 5,207 | $10.78 | $56,131.46 | -5.6% | → |
| 2024-11-18 | Xynos Konstantinos | Chief Medical Officer | Sell | 7,246 | $10.78 | $78,111.88 | -6.2% | → |
| 2024-08-16 | Hill Emily Luisa | Chief Financial Officer | Sell | 8,938 | $10.18 | $90,988.84 | -8.1% | → |
| 2024-06-07 | Xynos Konstantinos | Chief Medical Officer | Sell | 15,881 | $7.50 | $119,107.50 | -11.9% | → |
| 2024-05-16 | Sarchi Christopher | Chief Commercial Officer | Sell | 2,218 | $6.47 | $14,350.46 | -2.3% | → |
| 2024-05-16 | Xynos Konstantinos | Chief Medical Officer | Sell | 6,367 | $6.47 | $41,194.49 | -4.6% | → |
| 2024-05-16 | Coffin Robert | - | Sell | 11,464 | $6.47 | $74,172.08 | -0.6% | → |
| 2024-05-16 | Astley-Sparke Philip | Executive Chairman | Sell | 37,928 | $6.47 | $245,394.16 | -2.5% | → |
| 2024-05-16 | Patel Sushil | Chief Executive Officer | Sell | 20,194 | $6.47 | $130,655.18 | -8.7% | → |
| 2024-05-16 | Schwendenman Andrew | Chief Accounting Officer | Sell | 2,298 | $6.47 | $14,868.06 | -5.7% | → |
| 2024-05-16 | Love Colin | Chief Operating Officer | Sell | 17,615 | $6.47 | $113,969.05 | -2.2% | → |
| 2023-11-16 | Sarchi Christopher | Chief Commercial Officer | Sell | 5,255 | $10.92 | $57,384.60 | -6.8% | → |
| 2023-11-16 | Xynos Konstantinos | Chief Medical Officer | Sell | 7,313 | $10.92 | $79,857.96 | -6.1% | → |
| 2023-09-12 | Esposito Pamela | Chief Business Officer | Sale+OE | 5,658 | $20.01 | $113,213.58 | -1.1% | → |
| 2023-08-22 | Esposito Pamela | Chief Business Officer | Sale+OE | 18,600 | $20.01 | $372,186.00 | -6.6% | → |
| 2023-08-11 | Esposito Pamela | Chief Business Officer | Sale+OE | 1,400 | $20.00 | $28,000.00 | -0.5% | → |
| 2023-07-10 | Esposito Pamela | Chief Business Officer | Sale+OE | 20,000 | $21.58 | $431,540.73 | -3.6% | → |
| 2023-06-13 | Lewis Tanya | Chief Dev. Op. Officer | Sell | 12,860 | $24.06 | $309,394.95 | -4.5% | → |
| 2023-06-13 | Patel Sushil | Chief Strategy Officer | Sell | 5,698 | $24.04 | $137,008.27 | -1.9% | → |
| 2023-05-16 | Coffin Robert | President & Chief R&D Officer | Sell | 7,861 | $18.05 | $141,891.05 | -0.4% | → |
| 2023-05-16 | Patel Sushil | Chief Strategy Officer | Sell | 15,575 | $18.05 | $281,128.75 | -9.2% | → |
| 2023-05-16 | Franchi Jean M. | Chief Financial Officer | Sell | 11,351 | $18.05 | $204,885.55 | -8.1% | → |
| 2023-05-16 | Astley-Sparke Philip | Chief Executive Officer | Sell | 17,902 | $18.05 | $323,131.10 | -1.2% | → |
| 2023-05-16 | Esposito Pamela | Chief Business Officer | Sell | 5,966 | $18.05 | $107,686.30 | -2.2% | → |
| 2023-05-16 | Xynos Konstantinos | Chief Medical Officer | Sell | 771 | $18.05 | $13,916.55 | -0.6% | → |
| 2023-05-16 | Love Colin | Chief Operating Officer | Sell | 10,775 | $18.05 | $194,488.75 | -1.3% | → |
| 2023-05-16 | Lewis Tanya | Chief Dev. Op. Officer | Sell | 12,207 | $18.05 | $220,336.35 | -7.6% | → |
| 2022-12-09 | Esposito Pamela | Chief Business Officer | Sale+OE | 15,000 | $25.03 | $375,450.00 | -6.1% | → |
| 2022-05-16 | Astley-Sparke Philip | Chief Executive Officer | Sell | 9,632 | $14.59 | $140,530.88 | -0.7% | → |
| 2022-05-16 | Coffin Robert | President & Chief R&D Officer | Sell | 5,737 | $14.59 | $83,702.83 | -0.3% | → |
| 2022-05-16 | Patel Sushil | Chief Commercial Officer | Sell | 10,687 | $14.59 | $155,923.33 | -7.6% | → |
| 2022-05-16 | Lewis Tanya | Chief Dev. Op Officer | Sell | 5,473 | $14.59 | $79,851.07 | -4.3% | → |
| 2022-05-16 | Franchi Jean M. | Chief Financial Officer | Sell | 3,436 | $14.59 | $50,131.24 | -3.5% | → |
| 2022-05-16 | Esposito Pamela | Chief Business Officer | Sell | 3,507 | $14.59 | $51,167.13 | -1.5% | → |